VENUS MEDTECH (HANGZHOU) INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.62 HKD | -0.71% |
|
-.--% | -.--% |
| May. 13 | Venus Medtech Board Receives Internal Control Review Report from Consultant | MT |
| Apr. 01 | Venus Medtech Trims Loss in 2023 as Revenue Grows Nearly 21% | MT |
Evolution of the average Target Price on Venus Medtech (Hangzhou) Inc.
Price target over the last 5 years
History of analyst recommendation changes
fbe6261feea111f4fad7d9954174.mzxIJLpgecV8iKD9m44fV4_zLb44y1-OoxtIc74L4BE.2FYlUdA3Cr1OxOqr1rxMJOypaNBOnA7X4FYKFtZf1UX5DQlJgxktiA6-7Q~815369c9d3c58f47bd437ca22ae4d2ab
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
5.157
CNY
Average target price
7.414
CNY
Spread / Average Target
+43.78%
High Price Target
11.03
CNY
Spread / Highest target
+113.98%
Low Price Target
3.73
CNY
Spread / Lowest Target
-27.67%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
B
EPS Revisions
- Stock Market
- Equities
- 2500 Stock
- Consensus Venus Medtech (Hangzhou) Inc.
